Literature DB >> 8813664

Protein phosphotyrosine phosphatases in Ascaris suum muscle.

B Schmid1, M Wimmer, C Tag, R Hoffmann, H W Hofer.   

Abstract

Two forms of protein tyrosine phosphatases were partially purified from the musculo-cutaneous layer of Ascaris suum. A 50-55-kDa soluble form of the phosphatase cross-reacted with antisera raised against human PTP-1B and TC-PTP. Like the enzyme of human origin the phosphatase from Ascaris exhibited a preference for anionic substrates (tyrosine-phosphorylated carboxymethylated and maleylated lysozyme) and was inhibited by micromolar concentrations of vanadate, molybdate, Zn2+, heparin, and poly(Glu4Tyr). As revealed by immuno-cytochemistry, the phosphatase was mainly localized and appeared equally distributed in the cytoplasm, apart from the myofibrils, possibly in loose association with cytoskeletal elements. A second tyrosine phosphatase of 180 kDa molecular mass was mainly found in detergent extracts from a microsomal fraction. It showed no cross-reactivity with antisera raised against soluble mammalian phosphatases and dephosphorylated a basic substrate (Tyr-phosphorylated myelin basic protein). It was resistant to common inhibitors of mammalian tyrosine phosphatases except Zn2+ and thiol reagents.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8813664     DOI: 10.1016/0166-6851(96)02592-3

Source DB:  PubMed          Journal:  Mol Biochem Parasitol        ISSN: 0166-6851            Impact factor:   1.759


  4 in total

1.  Cryptosporidium parvum: identification and characterization of an acid phosphatase.

Authors:  María Magdalena Aguirre-García; Pablo C Okhuysen
Journal:  Parasitol Res       Date:  2007-01-25       Impact factor: 2.289

2.  Leishmania mexicana promastigotes secrete a protein tyrosine phosphatase.

Authors:  Alma R Escalona-Montaño; Daniel Pardavé-Alejandre; Rocely Cervantes-Sarabia; Patricia García-López; Manuel Gutiérrez-Quiroz; Laila Gutiérrez-Kobeh; Ingeborg Becker-Fauser; Maria M Aguirre-García
Journal:  Parasitol Res       Date:  2010-04-20       Impact factor: 2.289

Review 3.  Past and current perspective on new therapeutic targets for Type-II diabetes.

Authors:  Pradip D Patil; Umesh B Mahajan; Kalpesh R Patil; Sandip Chaudhari; Chandragouda R Patil; Yogeeta O Agrawal; Shreesh Ojha; Sameer N Goyal
Journal:  Drug Des Devel Ther       Date:  2017-05-22       Impact factor: 4.162

Review 4.  Epigenetic modification and therapeutic targets of diabetes mellitus.

Authors:  Velayutham Ravichandiran; Dipanjan Ghosh; Rajveer Singh; Shivani Chandel; Dhritiman Dey; Arijit Ghosh; Syamal Roy
Journal:  Biosci Rep       Date:  2020-09-30       Impact factor: 3.840

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.